ROBIN KOCHEL to Baclofen
This is a "connection" page, showing publications ROBIN KOCHEL has written about Baclofen.
Connection Strength
0.238
-
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome. Expert Rev Neurother. 2026 Jun; 26(6):597-607.
Score: 0.238
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.